Topic

Crysvita (burosumab)

A collection of 44 issues

The Complete Checklist to Get Crysvita (Burosumab) Covered by Cigna in California: Forms, Appeals, and Requirements

Answer Box: Fastest Path to Approval Getting Crysvita (burosumab) covered by Cigna in California requires prior authorization through Express Scripts/Accredo with specific documentation: confirmed XLH diagnosis (PHEX gene mutation or elevated FGF23), baseline low serum phosphorus, endocrinologist prescription, and failed oral phosphate therapy. First step today: Have your specialist
6 min read

Get Crysvita (Burosumab) Covered by UnitedHealthcare in North Carolina: Complete Prior Authorization and Appeals Guide

Answer Box: Getting Crysvita Covered by UnitedHealthcare in North Carolina Yes, UnitedHealthcare covers Crysvita (burosumab) for X-linked hypophosphatemia (XLH) and tumor-induced osteomalacia (TIO), but requires prior authorization through specialty providers. Your endocrinologist submits the PA via UnitedHealthcare's provider portal with genetic testing results, lab values, and treatment history.
7 min read

How to Get Crysvita (burosumab) Covered by Humana in Pennsylvania: Prior Authorization, Appeals, and Alternative Options

Answer Box: Getting Crysvita (burosumab) Covered by Humana in Pennsylvania Crysvita (burosumab) requires prior authorization from Humana in Pennsylvania. For Medicare Advantage members, submit PA documentation including genetic/FGF23 confirmation of XLH, baseline low serum phosphorus, and specialist attestation via Humana's provider portal. Standard review takes 72 hours;
7 min read

Get Crysvita (burosumab) Covered by Cigna in Illinois: Complete Prior Authorization and Appeals Guide

Answer Box: Getting Crysvita Covered by Cigna in Illinois Eligibility: Crysvita (burosumab) requires prior authorization from Cigna for X-linked hypophosphatemia (XLH) or tumor-induced osteomalacia (TIO). Fastest path: Have your specialist submit the Cigna Crysvita CCRD Prior Authorization Form with genetic testing (XLH) or tumor documentation (TIO), baseline fasting serum phosphorus
5 min read

How to Get Crysvita (Burosumab) Covered by UnitedHealthcare in California: Complete Prior Authorization Guide with ICD-10 and Appeals

Answer Box: Getting Crysvita Covered by UnitedHealthcare in California Crysvita (burosumab) requires prior authorization from UnitedHealthcare OptumRx. Submit PA requests through the UnitedHealthcare Provider Portal with genetic testing (PHEX mutation or elevated FGF23), documented failure of oral phosphate/calcitriol therapy, and endocrinologist involvement. If denied, file an internal appeal within
6 min read

How to Get Crysvita (burosumab) Covered by Anthem Blue Cross Blue Shield Virginia: Prior Authorization, Appeals & External Review Guide

Answer Box: Getting Crysvita Covered by Anthem BCBS Virginia Anthem Blue Cross Blue Shield Virginia requires prior authorization for Crysvita (burosumab) with strict clinical criteria. To get approval: (1) Your endocrinologist submits genetic XLH confirmation plus low serum phosphorus labs via Anthem's clinical criteria portal, (2) Document failed/
7 min read

Get Crysvita (Burosumab) Covered by UnitedHealthcare in New Jersey: Prior Authorization, Appeals & Cost Assistance Guide

Answer Box: Fast Track to Coverage Getting Crysvita (burosumab) covered by UnitedHealthcare in New Jersey requires prior authorization with genetic testing or elevated FGF23 levels, specialist involvement, and documentation of failed conventional therapy (especially for adults). Submit through the UnitedHealthcare provider portal with complete medical records. If denied, you have
6 min read

How to Get Crysvita (burosumab) Covered by UnitedHealthcare in Ohio: Complete Forms, Appeals, and Contact Guide

Answer Box: Getting Crysvita Covered in Ohio UnitedHealthcare requires prior authorization for Crysvita (burosumab) through OptumRx for X-linked hypophosphatemia (XLH) and tumor-induced osteomalacia. Submit via the UnitedHealthcare Provider Portal with genetic testing, low serum phosphorus labs, and specialist prescription. If denied, you have 180 days for internal appeals, then external
5 min read